nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—Idarubicin—breast cancer	0.127	0.685	CrCtD
Doxorubicin—Anthracyclines—Idarubicin—breast cancer	0.0779	0.321	CiPCiCtD
Doxorubicin—bone cancer—breast cancer	0.0693	0.531	CtDrD
Doxorubicin—ovarian cancer—breast cancer	0.0612	0.469	CtDrD
Doxorubicin—Epirubicin—breast cancer	0.0584	0.315	CrCtD
Doxorubicin—NDUFS3—breast cancer	0.0415	0.347	CbGaD
Doxorubicin—Topoisomerase Inhibitors—Idarubicin—breast cancer	0.0407	0.168	CiPCiCtD
Doxorubicin—Anthracyclines—Epirubicin—breast cancer	0.0358	0.148	CiPCiCtD
Doxorubicin—Topoisomerase Inhibitors—Mitoxantrone—breast cancer	0.0346	0.143	CiPCiCtD
Doxorubicin—Topoisomerase Inhibitors—Irinotecan—breast cancer	0.0346	0.143	CiPCiCtD
Doxorubicin—Epirubicin—Idarubicin—breast cancer	0.0272	0.228	CrCrCtD
Doxorubicin—Daunorubicin—Idarubicin—breast cancer	0.0272	0.228	CrCrCtD
Doxorubicin—Valrubicin—Idarubicin—breast cancer	0.0272	0.228	CrCrCtD
Doxorubicin—Topoisomerase Inhibitors—Epirubicin—breast cancer	0.0187	0.0771	CiPCiCtD
Doxorubicin—AURKA—breast cancer	0.0172	0.144	CbGaD
Doxorubicin—Daunorubicin—Epirubicin—breast cancer	0.0125	0.105	CrCrCtD
Doxorubicin—Valrubicin—Epirubicin—breast cancer	0.0125	0.105	CrCrCtD
Doxorubicin—Idarubicin—Epirubicin—breast cancer	0.0125	0.105	CrCrCtD
Doxorubicin—DHCR7—Tamoxifen—breast cancer	0.012	0.103	CbGbCtD
Doxorubicin—NQO1—breast cancer	0.00991	0.0827	CbGaD
Doxorubicin—YWHAG—Epirubicin—breast cancer	0.00944	0.081	CbGbCtD
Doxorubicin—AURKA—Epirubicin—breast cancer	0.00944	0.081	CbGbCtD
Doxorubicin—DHCR7—Epirubicin—breast cancer	0.00944	0.081	CbGbCtD
Doxorubicin—ABCC1—breast cancer	0.00898	0.075	CbGaD
Doxorubicin—NOS3—breast cancer	0.00836	0.0698	CbGaD
Doxorubicin—NOS2—breast cancer	0.00808	0.0674	CbGaD
Doxorubicin—TOP2A—breast cancer	0.00693	0.0579	CbGaD
Doxorubicin—CYP1B1—breast cancer	0.00687	0.0573	CbGaD
Doxorubicin—TOP2A—Idarubicin—breast cancer	0.00551	0.0473	CbGbCtD
Doxorubicin—ABCG2—breast cancer	0.00473	0.0395	CbGaD
Doxorubicin—NQO1—Carboplatin—breast cancer	0.004	0.0343	CbGbCtD
Doxorubicin—ABCC6—Vinblastine—breast cancer	0.00312	0.0268	CbGbCtD
Doxorubicin—ABCC1—Idarubicin—breast cancer	0.00305	0.0262	CbGbCtD
Doxorubicin—ABCC10—Gemcitabine—breast cancer	0.003	0.0258	CbGbCtD
Doxorubicin—CYP2D6—breast cancer	0.00276	0.023	CbGaD
Doxorubicin—ABCC10—Paclitaxel—breast cancer	0.00271	0.0233	CbGbCtD
Doxorubicin—TOP2A—Mitoxantrone—breast cancer	0.00237	0.0203	CbGbCtD
Doxorubicin—CYP3A4—breast cancer	0.00237	0.0198	CbGaD
Doxorubicin—XDH—Carboplatin—breast cancer	0.00209	0.0179	CbGbCtD
Doxorubicin—ABCB1—breast cancer	0.00197	0.0165	CbGaD
Doxorubicin—ABCC10—Docetaxel—breast cancer	0.00196	0.0168	CbGbCtD
Doxorubicin—TOP2A—Epirubicin—breast cancer	0.00192	0.0165	CbGbCtD
Doxorubicin—CYP1B1—Tamoxifen—breast cancer	0.0019	0.0163	CbGbCtD
Doxorubicin—ABCB11—Tamoxifen—breast cancer	0.0019	0.0163	CbGbCtD
Doxorubicin—CYP1B1—Mitoxantrone—breast cancer	0.00185	0.0159	CbGbCtD
Doxorubicin—ABCC3—Fluorouracil—breast cancer	0.00162	0.0139	CbGbCtD
Doxorubicin—CYP1B1—Paclitaxel—breast cancer	0.00148	0.0127	CbGbCtD
Doxorubicin—ABCB11—Paclitaxel—breast cancer	0.00148	0.0127	CbGbCtD
Doxorubicin—CYP2B6—Thiotepa—breast cancer	0.00144	0.0123	CbGbCtD
Doxorubicin—ABCC10—Methotrexate—breast cancer	0.00142	0.0122	CbGbCtD
Doxorubicin—ABCC1—Mitoxantrone—breast cancer	0.00131	0.0113	CbGbCtD
Doxorubicin—ABCB11—Vinblastine—breast cancer	0.00129	0.0111	CbGbCtD
Doxorubicin—CYP1B1—Docetaxel—breast cancer	0.00107	0.00916	CbGbCtD
Doxorubicin—ABCC1—Epirubicin—breast cancer	0.00106	0.00912	CbGbCtD
Doxorubicin—ABCC1—Paclitaxel—breast cancer	0.00105	0.009	CbGbCtD
Doxorubicin—ABCC1—Irinotecan—breast cancer	0.00103	0.00888	CbGbCtD
Doxorubicin—ABCC2—Tamoxifen—breast cancer	0.000997	0.00856	CbGbCtD
Doxorubicin—CYP2B6—Raloxifene—breast cancer	0.000959	0.00823	CbGbCtD
Doxorubicin—ABCC1—Vinblastine—breast cancer	0.000919	0.00789	CbGbCtD
Doxorubicin—ABCG2—Tamoxifen—breast cancer	0.000901	0.00774	CbGbCtD
Doxorubicin—ABCC3—Methotrexate—breast cancer	0.000891	0.00765	CbGbCtD
Doxorubicin—ABCB1—Toremifene—breast cancer	0.00089	0.00764	CbGbCtD
Doxorubicin—ABCG2—Mitoxantrone—breast cancer	0.000879	0.00754	CbGbCtD
Doxorubicin—ABCC2—Paclitaxel—breast cancer	0.000776	0.00666	CbGbCtD
Doxorubicin—CYP3A4—Exemestane—breast cancer	0.000769	0.0066	CbGbCtD
Doxorubicin—ABCC2—Irinotecan—breast cancer	0.000765	0.00657	CbGbCtD
Doxorubicin—ABCC1—Docetaxel—breast cancer	0.000758	0.00651	CbGbCtD
Doxorubicin—ABCC2—Carboplatin—breast cancer	0.00073	0.00627	CbGbCtD
Doxorubicin—ABCG2—Paclitaxel—breast cancer	0.000701	0.00602	CbGbCtD
Doxorubicin—CYP2D6—Idarubicin—breast cancer	0.000695	0.00596	CbGbCtD
Doxorubicin—ABCG2—Irinotecan—breast cancer	0.000692	0.00594	CbGbCtD
Doxorubicin—ABCC2—Vinblastine—breast cancer	0.00068	0.00584	CbGbCtD
Doxorubicin—ABCG2—Fluorouracil—breast cancer	0.000664	0.0057	CbGbCtD
Doxorubicin—ABCG2—Carboplatin—breast cancer	0.00066	0.00567	CbGbCtD
Doxorubicin—CYP3A4—Letrozole—breast cancer	0.000654	0.00561	CbGbCtD
Doxorubicin—ABCB1—Lapatinib—breast cancer	0.000649	0.00557	CbGbCtD
Doxorubicin—CYP2B6—Tamoxifen—breast cancer	0.000634	0.00544	CbGbCtD
Doxorubicin—CYP3A4—Anastrozole—breast cancer	0.000583	0.005	CbGbCtD
Doxorubicin—ABCC2—Docetaxel—breast cancer	0.000561	0.00482	CbGbCtD
Doxorubicin—ABCC1—Methotrexate—breast cancer	0.000547	0.0047	CbGbCtD
Doxorubicin—CYP3A4—Toremifene—breast cancer	0.000533	0.00458	CbGbCtD
Doxorubicin—ABCG2—Docetaxel—breast cancer	0.000507	0.00435	CbGbCtD
Doxorubicin—CYP3A4—Fulvestrant—breast cancer	0.000495	0.00425	CbGbCtD
Doxorubicin—CYP2B6—Irinotecan—breast cancer	0.000487	0.00418	CbGbCtD
Doxorubicin—CYP3A4—Thiotepa—breast cancer	0.000442	0.00379	CbGbCtD
Doxorubicin—ABCC2—Methotrexate—breast cancer	0.000405	0.00348	CbGbCtD
Doxorubicin—CYP3A4—Ixabepilone—breast cancer	0.000404	0.00347	CbGbCtD
Doxorubicin—CYP3A4—Lapatinib—breast cancer	0.000389	0.00334	CbGbCtD
Doxorubicin—ABCG2—Methotrexate—breast cancer	0.000366	0.00314	CbGbCtD
Doxorubicin—ABCB1—Vinorelbine—breast cancer	0.00036	0.00309	CbGbCtD
Doxorubicin—NOS3—umbilical vein—breast cancer	0.000349	0.022	CbGeAlD
Doxorubicin—CYP2D6—Vinorelbine—breast cancer	0.000339	0.00291	CbGbCtD
Doxorubicin—ABCB1—Tamoxifen—breast cancer	0.000325	0.00279	CbGbCtD
Doxorubicin—ABCB1—Mitoxantrone—breast cancer	0.000317	0.00272	CbGbCtD
Doxorubicin—CYP2D6—Tamoxifen—breast cancer	0.000306	0.00263	CbGbCtD
Doxorubicin—CYP3A4—Raloxifene—breast cancer	0.000295	0.00253	CbGbCtD
Doxorubicin—ABCB1—Gemcitabine—breast cancer	0.00028	0.0024	CbGbCtD
Doxorubicin—ABCB1—Paclitaxel—breast cancer	0.000253	0.00217	CbGbCtD
Doxorubicin—ABCB1—Irinotecan—breast cancer	0.00025	0.00214	CbGbCtD
Doxorubicin—CBR3—nipple—breast cancer	0.000248	0.0157	CbGeAlD
Doxorubicin—AKR1A1—mammary gland—breast cancer	0.000231	0.0146	CbGeAlD
Doxorubicin—ABCB1—Vinblastine—breast cancer	0.000222	0.0019	CbGbCtD
Doxorubicin—CYP3A4—Vinorelbine—breast cancer	0.000216	0.00185	CbGbCtD
Doxorubicin—CYP2D6—Vinblastine—breast cancer	0.000209	0.00179	CbGbCtD
Doxorubicin—CBR3—embryo—breast cancer	0.000204	0.0129	CbGeAlD
Doxorubicin—AURKA—mammary gland—breast cancer	0.000195	0.0123	CbGeAlD
Doxorubicin—NOS2—adrenal gland—breast cancer	0.000195	0.0123	CbGeAlD
Doxorubicin—CYP3A4—Tamoxifen—breast cancer	0.000195	0.00167	CbGbCtD
Doxorubicin—AKR1A1—nipple—breast cancer	0.000191	0.0121	CbGeAlD
Doxorubicin—CYP3A4—Mitoxantrone—breast cancer	0.00019	0.00163	CbGbCtD
Doxorubicin—ABCB1—Docetaxel—breast cancer	0.000183	0.00157	CbGbCtD
Doxorubicin—SLC22A16—female reproductive system—breast cancer	0.000166	0.0105	CbGeAlD
Doxorubicin—DHCR7—mammary gland—breast cancer	0.000164	0.0103	CbGeAlD
Doxorubicin—SLC22A16—bone marrow—breast cancer	0.000156	0.00987	CbGeAlD
Doxorubicin—CYP3A4—Paclitaxel—breast cancer	0.000152	0.0013	CbGbCtD
Doxorubicin—YWHAG—mammary gland—breast cancer	0.00015	0.00948	CbGeAlD
Doxorubicin—CBR3—endometrium—breast cancer	0.00015	0.00945	CbGeAlD
Doxorubicin—CYP3A4—Irinotecan—breast cancer	0.000149	0.00128	CbGbCtD
Doxorubicin—Epirubicin—AURKA—breast cancer	0.000145	0.157	CrCbGaD
Doxorubicin—NDUFS2—nipple—breast cancer	0.000144	0.0091	CbGeAlD
Doxorubicin—NDUFS3—nipple—breast cancer	0.000142	0.00899	CbGeAlD
Doxorubicin—ABCB8—pituitary gland—breast cancer	0.000141	0.00889	CbGeAlD
Doxorubicin—SLC22A16—endocrine gland—breast cancer	0.00014	0.00885	CbGeAlD
Doxorubicin—ABCB8—adipose tissue—breast cancer	0.00014	0.00885	CbGeAlD
Doxorubicin—DHCR7—nipple—breast cancer	0.000135	0.00854	CbGeAlD
Doxorubicin—CBR3—adipose tissue—breast cancer	0.000135	0.00852	CbGeAlD
Doxorubicin—Valrubicin—TOP2A—breast cancer	0.000133	0.145	CrCbGaD
Doxorubicin—NOS3—mammary gland—breast cancer	0.000133	0.00842	CbGeAlD
Doxorubicin—CYP3A4—Vinblastine—breast cancer	0.000133	0.00114	CbGbCtD
Doxorubicin—ABCB1—Methotrexate—breast cancer	0.000132	0.00113	CbGbCtD
Doxorubicin—ABCB8—female reproductive system—breast cancer	0.000129	0.00813	CbGeAlD
Doxorubicin—CBR1—mammary gland—breast cancer	0.000126	0.00799	CbGeAlD
Doxorubicin—ABCB8—adrenal gland—breast cancer	0.000126	0.00794	CbGeAlD
Doxorubicin—YWHAG—nipple—breast cancer	0.000124	0.00784	CbGeAlD
Doxorubicin—CBR3—female reproductive system—breast cancer	0.000124	0.00783	CbGeAlD
Doxorubicin—AKR1A1—skin of body—breast cancer	0.000123	0.00774	CbGeAlD
Doxorubicin—CBR3—adrenal gland—breast cancer	0.000121	0.00764	CbGeAlD
Doxorubicin—ABCB8—female gonad—breast cancer	0.000117	0.0074	CbGeAlD
Doxorubicin—AKR1A1—endometrium—breast cancer	0.000116	0.0073	CbGeAlD
Doxorubicin—CBR3—female gonad—breast cancer	0.000113	0.00712	CbGeAlD
Doxorubicin—RALBP1—nipple—breast cancer	0.000112	0.00708	CbGeAlD
Doxorubicin—CYP3A4—Docetaxel—breast cancer	0.00011	0.00094	CbGbCtD
Doxorubicin—ABCB8—endocrine gland—breast cancer	0.000109	0.00688	CbGeAlD
Doxorubicin—AKR1A1—uterus—breast cancer	0.000106	0.00672	CbGeAlD
Doxorubicin—CBR1—nipple—breast cancer	0.000105	0.00661	CbGeAlD
Doxorubicin—AKR1A1—pituitary gland—breast cancer	0.000105	0.0066	CbGeAlD
Doxorubicin—AKR1A1—adipose tissue—breast cancer	0.000104	0.00658	CbGeAlD
Doxorubicin—AKR1C3—nipple—breast cancer	0.000103	0.00653	CbGeAlD
Doxorubicin—NQO1—mammary gland—breast cancer	0.000101	0.0064	CbGeAlD
Doxorubicin—Idarubicin—ABCC1—breast cancer	9.93e-05	0.108	CrCbGaD
Doxorubicin—NOS1—epithelium—breast cancer	9.76e-05	0.00617	CbGeAlD
Doxorubicin—AURKA—endometrium—breast cancer	9.76e-05	0.00617	CbGeAlD
Doxorubicin—AKR1A1—female reproductive system—breast cancer	9.57e-05	0.00605	CbGeAlD
Doxorubicin—NDUFS7—adipose tissue—breast cancer	9.46e-05	0.00598	CbGeAlD
Doxorubicin—POR—nipple—breast cancer	9.44e-05	0.00596	CbGeAlD
Doxorubicin—AKR1A1—adrenal gland—breast cancer	9.34e-05	0.0059	CbGeAlD
Doxorubicin—Epirubicin—PLA2G4A—breast cancer	9.31e-05	0.101	CrCbGaD
Doxorubicin—NDUFS2—skin of body—breast cancer	9.23e-05	0.00583	CbGeAlD
Doxorubicin—NDUFS3—skin of body—breast cancer	9.12e-05	0.00576	CbGeAlD
Doxorubicin—AKR1A1—bone marrow—breast cancer	9.04e-05	0.00571	CbGeAlD
Doxorubicin—AURKA—uterus—breast cancer	9e-05	0.00568	CbGeAlD
Doxorubicin—AURKA—pituitary gland—breast cancer	8.83e-05	0.00558	CbGeAlD
Doxorubicin—TOP2A—nipple—breast cancer	8.79e-05	0.00555	CbGeAlD
Doxorubicin—AKR1A1—female gonad—breast cancer	8.71e-05	0.0055	CbGeAlD
Doxorubicin—NDUFS2—endometrium—breast cancer	8.7e-05	0.0055	CbGeAlD
Doxorubicin—NDUFS7—female reproductive system—breast cancer	8.7e-05	0.00549	CbGeAlD
Doxorubicin—DHCR7—skin of body—breast cancer	8.66e-05	0.00547	CbGeAlD
Doxorubicin—NDUFS3—endometrium—breast cancer	8.59e-05	0.00543	CbGeAlD
Doxorubicin—NDUFS7—adrenal gland—breast cancer	8.49e-05	0.00536	CbGeAlD
Doxorubicin—NQO1—nipple—breast cancer	8.38e-05	0.00529	CbGeAlD
Doxorubicin—NDUFS7—bone marrow—breast cancer	8.21e-05	0.00519	CbGeAlD
Doxorubicin—AKR1A1—endocrine gland—breast cancer	8.1e-05	0.00512	CbGeAlD
Doxorubicin—AURKA—female reproductive system—breast cancer	8.09e-05	0.00511	CbGeAlD
Doxorubicin—NDUFS2—uterus—breast cancer	8.02e-05	0.00506	CbGeAlD
Doxorubicin—NDUFS3—uterus—breast cancer	7.92e-05	0.005	CbGeAlD
Doxorubicin—NDUFS7—female gonad—breast cancer	7.91e-05	0.005	CbGeAlD
Doxorubicin—AURKA—adrenal gland—breast cancer	7.89e-05	0.00498	CbGeAlD
Doxorubicin—NDUFS2—pituitary gland—breast cancer	7.87e-05	0.00497	CbGeAlD
Doxorubicin—NDUFS2—adipose tissue—breast cancer	7.84e-05	0.00495	CbGeAlD
Doxorubicin—NDUFS3—pituitary gland—breast cancer	7.78e-05	0.00491	CbGeAlD
Doxorubicin—NDUFS3—adipose tissue—breast cancer	7.75e-05	0.00489	CbGeAlD
Doxorubicin—Idarubicin—TOP2A—breast cancer	7.66e-05	0.0831	CrCbGaD
Doxorubicin—AURKA—bone marrow—breast cancer	7.63e-05	0.00482	CbGeAlD
Doxorubicin—ABCB8—lymph node—breast cancer	7.53e-05	0.00476	CbGeAlD
Doxorubicin—Epirubicin—ABCC1—breast cancer	7.53e-05	0.0817	CrCbGaD
Doxorubicin—YWHAG—endometrium—breast cancer	7.49e-05	0.00473	CbGeAlD
Doxorubicin—ABCC10—nipple—breast cancer	7.49e-05	0.00473	CbGeAlD
Doxorubicin—NOS3—epithelium—breast cancer	7.42e-05	0.00469	CbGeAlD
Doxorubicin—DHCR7—pituitary gland—breast cancer	7.39e-05	0.00467	CbGeAlD
Doxorubicin—NDUFS7—endocrine gland—breast cancer	7.36e-05	0.00465	CbGeAlD
Doxorubicin—DHCR7—adipose tissue—breast cancer	7.36e-05	0.00465	CbGeAlD
Doxorubicin—AURKA—female gonad—breast cancer	7.36e-05	0.00465	CbGeAlD
Doxorubicin—XDH—endometrium—breast cancer	7.31e-05	0.00462	CbGeAlD
Doxorubicin—NOS1—female reproductive system—breast cancer	7.25e-05	0.00458	CbGeAlD
Doxorubicin—CBR3—lymph node—breast cancer	7.25e-05	0.00458	CbGeAlD
Doxorubicin—NDUFS2—female reproductive system—breast cancer	7.21e-05	0.00455	CbGeAlD
Doxorubicin—ABCC6—adipose tissue—breast cancer	7.17e-05	0.00453	CbGeAlD
Doxorubicin—NDUFS3—female reproductive system—breast cancer	7.12e-05	0.0045	CbGeAlD
Doxorubicin—CYP1B1—mammary gland—breast cancer	7.12e-05	0.0045	CbGeAlD
Doxorubicin—NDUFS2—adrenal gland—breast cancer	7.03e-05	0.00444	CbGeAlD
Doxorubicin—NDUFS3—adrenal gland—breast cancer	6.95e-05	0.00439	CbGeAlD
Doxorubicin—YWHAG—uterus—breast cancer	6.9e-05	0.00436	CbGeAlD
Doxorubicin—AURKA—endocrine gland—breast cancer	6.84e-05	0.00432	CbGeAlD
Doxorubicin—NDUFS2—bone marrow—breast cancer	6.8e-05	0.0043	CbGeAlD
Doxorubicin—YWHAG—pituitary gland—breast cancer	6.78e-05	0.00428	CbGeAlD
Doxorubicin—RALBP1—endometrium—breast cancer	6.77e-05	0.00427	CbGeAlD
Doxorubicin—DHCR7—female reproductive system—breast cancer	6.76e-05	0.00427	CbGeAlD
Doxorubicin—YWHAG—adipose tissue—breast cancer	6.75e-05	0.00427	CbGeAlD
Doxorubicin—NDUFS3—bone marrow—breast cancer	6.72e-05	0.00425	CbGeAlD
Doxorubicin—CBR1—skin of body—breast cancer	6.7e-05	0.00423	CbGeAlD
Doxorubicin—DHCR7—adrenal gland—breast cancer	6.6e-05	0.00417	CbGeAlD
Doxorubicin—NDUFS2—female gonad—breast cancer	6.56e-05	0.00414	CbGeAlD
Doxorubicin—NDUFS3—female gonad—breast cancer	6.48e-05	0.00409	CbGeAlD
Doxorubicin—DHCR7—bone marrow—breast cancer	6.39e-05	0.00403	CbGeAlD
Doxorubicin—CBR1—endometrium—breast cancer	6.32e-05	0.00399	CbGeAlD
Doxorubicin—AKR1C3—endometrium—breast cancer	6.24e-05	0.00394	CbGeAlD
Doxorubicin—RALBP1—uterus—breast cancer	6.24e-05	0.00394	CbGeAlD
Doxorubicin—YWHAG—female reproductive system—breast cancer	6.21e-05	0.00392	CbGeAlD
Doxorubicin—DHCR7—female gonad—breast cancer	6.16e-05	0.00389	CbGeAlD
Doxorubicin—NOS1—endocrine gland—breast cancer	6.14e-05	0.00388	CbGeAlD
Doxorubicin—RALBP1—pituitary gland—breast cancer	6.12e-05	0.00387	CbGeAlD
Doxorubicin—NDUFS2—endocrine gland—breast cancer	6.1e-05	0.00385	CbGeAlD
Doxorubicin—RALBP1—adipose tissue—breast cancer	6.1e-05	0.00385	CbGeAlD
Doxorubicin—YWHAG—adrenal gland—breast cancer	6.06e-05	0.00383	CbGeAlD
Doxorubicin—XDH—female reproductive system—breast cancer	6.05e-05	0.00382	CbGeAlD
Doxorubicin—NDUFS3—endocrine gland—breast cancer	6.02e-05	0.00381	CbGeAlD
Doxorubicin—AURKA—Chlorambucil—Melphalan—breast cancer	5.91e-05	0.0901	CbGdCrCtD
Doxorubicin—YWHAG—bone marrow—breast cancer	5.86e-05	0.0037	CbGeAlD
Doxorubicin—CBR1—uterus—breast cancer	5.82e-05	0.00368	CbGeAlD
Doxorubicin—Epirubicin—TOP2A—breast cancer	5.81e-05	0.063	CrCbGaD
Doxorubicin—AKR1C3—uterus—breast cancer	5.75e-05	0.00363	CbGeAlD
Doxorubicin—DHCR7—endocrine gland—breast cancer	5.72e-05	0.00362	CbGeAlD
Doxorubicin—CBR1—pituitary gland—breast cancer	5.72e-05	0.00361	CbGeAlD
Doxorubicin—POR—endometrium—breast cancer	5.7e-05	0.0036	CbGeAlD
Doxorubicin—CBR1—adipose tissue—breast cancer	5.69e-05	0.0036	CbGeAlD
Doxorubicin—YWHAG—female gonad—breast cancer	5.65e-05	0.00357	CbGeAlD
Doxorubicin—AKR1C3—pituitary gland—breast cancer	5.65e-05	0.00357	CbGeAlD
Doxorubicin—NQO1—epithelium—breast cancer	5.64e-05	0.00356	CbGeAlD
Doxorubicin—AKR1C3—adipose tissue—breast cancer	5.62e-05	0.00355	CbGeAlD
Doxorubicin—RALBP1—female reproductive system—breast cancer	5.61e-05	0.00354	CbGeAlD
Doxorubicin—AKR1A1—lymph node—breast cancer	5.6e-05	0.00354	CbGeAlD
Doxorubicin—ABCC6—endocrine gland—breast cancer	5.58e-05	0.00352	CbGeAlD
Doxorubicin—NOS3—female reproductive system—breast cancer	5.51e-05	0.00348	CbGeAlD
Doxorubicin—RALBP1—adrenal gland—breast cancer	5.47e-05	0.00346	CbGeAlD
Doxorubicin—NOS3—adrenal gland—breast cancer	5.38e-05	0.0034	CbGeAlD
Doxorubicin—NQO1—skin of body—breast cancer	5.37e-05	0.00339	CbGeAlD
Doxorubicin—Daunorubicin—ABCC1—breast cancer	5.32e-05	0.0578	CrCbGaD
Doxorubicin—TOP2A—endometrium—breast cancer	5.31e-05	0.00335	CbGeAlD
Doxorubicin—ABCC1—nipple—breast cancer	5.29e-05	0.00334	CbGeAlD
Doxorubicin—RALBP1—bone marrow—breast cancer	5.29e-05	0.00334	CbGeAlD
Doxorubicin—YWHAG—endocrine gland—breast cancer	5.25e-05	0.00332	CbGeAlD
Doxorubicin—CBR1—female reproductive system—breast cancer	5.23e-05	0.00331	CbGeAlD
Doxorubicin—POR—pituitary gland—breast cancer	5.16e-05	0.00326	CbGeAlD
Doxorubicin—POR—adipose tissue—breast cancer	5.13e-05	0.00324	CbGeAlD
Doxorubicin—XDH—endocrine gland—breast cancer	5.12e-05	0.00324	CbGeAlD
Doxorubicin—CBR1—adrenal gland—breast cancer	5.11e-05	0.00323	CbGeAlD
Doxorubicin—RALBP1—female gonad—breast cancer	5.1e-05	0.00322	CbGeAlD
Doxorubicin—NDUFS7—lymph node—breast cancer	5.09e-05	0.00321	CbGeAlD
Doxorubicin—NQO1—endometrium—breast cancer	5.06e-05	0.0032	CbGeAlD
Doxorubicin—AKR1C3—adrenal gland—breast cancer	5.04e-05	0.00319	CbGeAlD
Doxorubicin—ABCB11—endocrine gland—breast cancer	5e-05	0.00316	CbGeAlD
Doxorubicin—CBR1—bone marrow—breast cancer	4.94e-05	0.00312	CbGeAlD
Doxorubicin—TOP2A—uterus—breast cancer	4.89e-05	0.00309	CbGeAlD
Doxorubicin—AKR1C3—bone marrow—breast cancer	4.88e-05	0.00308	CbGeAlD
Doxorubicin—TOP2A—adipose tissue—breast cancer	4.79e-05	0.00302	CbGeAlD
Doxorubicin—CBR1—female gonad—breast cancer	4.76e-05	0.00301	CbGeAlD
Doxorubicin—RALBP1—endocrine gland—breast cancer	4.74e-05	0.003	CbGeAlD
Doxorubicin—AURKA—lymph node—breast cancer	4.73e-05	0.00299	CbGeAlD
Doxorubicin—AKR1C3—female gonad—breast cancer	4.7e-05	0.00297	CbGeAlD
Doxorubicin—NOS3—endocrine gland—breast cancer	4.67e-05	0.00295	CbGeAlD
Doxorubicin—NQO1—uterus—breast cancer	4.66e-05	0.00295	CbGeAlD
Doxorubicin—POR—adrenal gland—breast cancer	4.61e-05	0.00291	CbGeAlD
Doxorubicin—NQO1—pituitary gland—breast cancer	4.58e-05	0.00289	CbGeAlD
Doxorubicin—NQO1—adipose tissue—breast cancer	4.56e-05	0.00288	CbGeAlD
Doxorubicin—ABCC10—endometrium—breast cancer	4.52e-05	0.00286	CbGeAlD
Doxorubicin—POR—bone marrow—breast cancer	4.46e-05	0.00281	CbGeAlD
Doxorubicin—CBR1—endocrine gland—breast cancer	4.43e-05	0.0028	CbGeAlD
Doxorubicin—POR—female gonad—breast cancer	4.29e-05	0.00271	CbGeAlD
Doxorubicin—TOP2A—adrenal gland—breast cancer	4.29e-05	0.00271	CbGeAlD
Doxorubicin—NDUFS2—lymph node—breast cancer	4.22e-05	0.00266	CbGeAlD
Doxorubicin—NQO1—female reproductive system—breast cancer	4.19e-05	0.00265	CbGeAlD
Doxorubicin—ABCC10—uterus—breast cancer	4.17e-05	0.00263	CbGeAlD
Doxorubicin—NDUFS3—lymph node—breast cancer	4.16e-05	0.00263	CbGeAlD
Doxorubicin—TOP2A—bone marrow—breast cancer	4.15e-05	0.00262	CbGeAlD
Doxorubicin—Daunorubicin—TOP2A—breast cancer	4.11e-05	0.0446	CrCbGaD
Doxorubicin—ABCC3—adipose tissue—breast cancer	4.09e-05	0.00259	CbGeAlD
Doxorubicin—NQO1—adrenal gland—breast cancer	4.09e-05	0.00258	CbGeAlD
Doxorubicin—ABCC10—pituitary gland—breast cancer	4.09e-05	0.00258	CbGeAlD
Doxorubicin—ABCC10—adipose tissue—breast cancer	4.07e-05	0.00257	CbGeAlD
Doxorubicin—Daunorubicin—CYP1B1—breast cancer	4.07e-05	0.0442	CrCbGaD
Doxorubicin—TOP2A—female gonad—breast cancer	4e-05	0.00253	CbGeAlD
Doxorubicin—POR—endocrine gland—breast cancer	3.99e-05	0.00252	CbGeAlD
Doxorubicin—DHCR7—lymph node—breast cancer	3.96e-05	0.0025	CbGeAlD
Doxorubicin—NQO1—female gonad—breast cancer	3.81e-05	0.00241	CbGeAlD
Doxorubicin—NQO1—Vincristine—Vinorelbine—breast cancer	3.79e-05	0.0579	CbGdCrCtD
Doxorubicin—CYP1B1—skin of body—breast cancer	3.77e-05	0.00238	CbGeAlD
Doxorubicin—ABCC3—female reproductive system—breast cancer	3.76e-05	0.00238	CbGeAlD
Doxorubicin—ABCC10—female reproductive system—breast cancer	3.74e-05	0.00237	CbGeAlD
Doxorubicin—ABCC3—adrenal gland—breast cancer	3.67e-05	0.00232	CbGeAlD
Doxorubicin—ABCC10—adrenal gland—breast cancer	3.65e-05	0.00231	CbGeAlD
Doxorubicin—YWHAG—lymph node—breast cancer	3.63e-05	0.00229	CbGeAlD
Doxorubicin—NQO1—endocrine gland—breast cancer	3.55e-05	0.00224	CbGeAlD
Doxorubicin—ABCC10—bone marrow—breast cancer	3.53e-05	0.00223	CbGeAlD
Doxorubicin—ABCC3—female gonad—breast cancer	3.42e-05	0.00216	CbGeAlD
Doxorubicin—AURKA—Topotecan—Irinotecan—breast cancer	3.41e-05	0.052	CbGdCrCtD
Doxorubicin—ABCC10—female gonad—breast cancer	3.41e-05	0.00215	CbGeAlD
Doxorubicin—CBR3—Daunorubicin—Idarubicin—breast cancer	3.31e-05	0.0506	CbGdCrCtD
Doxorubicin—CBR3—Epirubicin—Idarubicin—breast cancer	3.31e-05	0.0506	CbGdCrCtD
Doxorubicin—RALBP1—lymph node—breast cancer	3.28e-05	0.00207	CbGeAlD
Doxorubicin—CYP1B1—uterus—breast cancer	3.28e-05	0.00207	CbGeAlD
Doxorubicin—NOS3—lymph node—breast cancer	3.23e-05	0.00204	CbGeAlD
Doxorubicin—CYP1B1—pituitary gland—breast cancer	3.22e-05	0.00203	CbGeAlD
Doxorubicin—CYP1B1—adipose tissue—breast cancer	3.2e-05	0.00202	CbGeAlD
Doxorubicin—ABCC1—endometrium—breast cancer	3.2e-05	0.00202	CbGeAlD
Doxorubicin—ABCC3—endocrine gland—breast cancer	3.18e-05	0.00201	CbGeAlD
Doxorubicin—ABCC10—endocrine gland—breast cancer	3.17e-05	0.002	CbGeAlD
Doxorubicin—CBR1—lymph node—breast cancer	3.06e-05	0.00193	CbGeAlD
Doxorubicin—Idarubicin—CYP2D6—breast cancer	3.05e-05	0.0331	CrCbGaD
Doxorubicin—NQO1—Vincristine—Vinblastine—breast cancer	3.03e-05	0.0463	CbGdCrCtD
Doxorubicin—AKR1C3—Vincristine—Vinorelbine—breast cancer	3.03e-05	0.0463	CbGdCrCtD
Doxorubicin—AKR1C3—lymph node—breast cancer	3.02e-05	0.00191	CbGeAlD
Doxorubicin—ABCC2—female reproductive system—breast cancer	3.01e-05	0.0019	CbGeAlD
Doxorubicin—ABCC1—uterus—breast cancer	2.95e-05	0.00186	CbGeAlD
Doxorubicin—CYP1B1—female reproductive system—breast cancer	2.94e-05	0.00186	CbGeAlD
Doxorubicin—ABCC2—adrenal gland—breast cancer	2.93e-05	0.00185	CbGeAlD
Doxorubicin—ABCC1—pituitary gland—breast cancer	2.89e-05	0.00183	CbGeAlD
Doxorubicin—ABCC1—adipose tissue—breast cancer	2.88e-05	0.00182	CbGeAlD
Doxorubicin—CYP1B1—adrenal gland—breast cancer	2.87e-05	0.00181	CbGeAlD
Doxorubicin—Daunorubicin—ABCG2—breast cancer	2.81e-05	0.0305	CrCbGaD
Doxorubicin—POR—lymph node—breast cancer	2.76e-05	0.00174	CbGeAlD
Doxorubicin—CYP1B1—female gonad—breast cancer	2.68e-05	0.00169	CbGeAlD
Doxorubicin—ABCG2—endometrium—breast cancer	2.65e-05	0.00167	CbGeAlD
Doxorubicin—CYP2B6—skin of body—breast cancer	2.59e-05	0.00164	CbGeAlD
Doxorubicin—ABCC1—adrenal gland—breast cancer	2.58e-05	0.00163	CbGeAlD
Doxorubicin—TOP2A—lymph node—breast cancer	2.57e-05	0.00163	CbGeAlD
Doxorubicin—ABCC2—endocrine gland—breast cancer	2.54e-05	0.00161	CbGeAlD
Doxorubicin—CYP1B1—endocrine gland—breast cancer	2.49e-05	0.00157	CbGeAlD
Doxorubicin—NQO1—lymph node—breast cancer	2.45e-05	0.00155	CbGeAlD
Doxorubicin—ABCG2—uterus—breast cancer	2.44e-05	0.00154	CbGeAlD
Doxorubicin—AKR1C3—Vinblastine—Vinorelbine—breast cancer	2.44e-05	0.0372	CbGdCrCtD
Doxorubicin—AKR1C3—Vincristine—Vinblastine—breast cancer	2.42e-05	0.037	CbGdCrCtD
Doxorubicin—ABCC1—female gonad—breast cancer	2.41e-05	0.00152	CbGeAlD
Doxorubicin—ABCG2—pituitary gland—breast cancer	2.4e-05	0.00151	CbGeAlD
Doxorubicin—ABCG2—adipose tissue—breast cancer	2.39e-05	0.00151	CbGeAlD
Doxorubicin—CBR3—Fluorometholone—Fluoxymesterone—breast cancer	2.38e-05	0.0363	CbGdCrCtD
Doxorubicin—CBR1—Vincristine—Vinorelbine—breast cancer	2.31e-05	0.0353	CbGdCrCtD
Doxorubicin—ABCC3—lymph node—breast cancer	2.2e-05	0.00139	CbGeAlD
Doxorubicin—Daunorubicin—CYP1A1—breast cancer	2.2e-05	0.0239	CrCbGaD
Doxorubicin—ABCC10—lymph node—breast cancer	2.19e-05	0.00138	CbGeAlD
Doxorubicin—ABCG2—adrenal gland—breast cancer	2.14e-05	0.00135	CbGeAlD
Doxorubicin—ABCG2—bone marrow—breast cancer	2.07e-05	0.00131	CbGeAlD
Doxorubicin—CYP2B6—female reproductive system—breast cancer	2.02e-05	0.00128	CbGeAlD
Doxorubicin—ABCG2—female gonad—breast cancer	2e-05	0.00126	CbGeAlD
Doxorubicin—CYP2B6—adrenal gland—breast cancer	1.97e-05	0.00125	CbGeAlD
Doxorubicin—CBR3—Triamcinolone—Fluoxymesterone—breast cancer	1.96e-05	0.03	CbGdCrCtD
Doxorubicin—CBR1—Vincristine—Vinblastine—breast cancer	1.85e-05	0.0282	CbGdCrCtD
Doxorubicin—TOP2A—Docetaxel—Paclitaxel—breast cancer	1.83e-05	0.028	CbGdCrCtD
Doxorubicin—TOP2A—Gefitinib—Lapatinib—breast cancer	1.8e-05	0.0274	CbGdCrCtD
Doxorubicin—ABCB1—embryo—breast cancer	1.78e-05	0.00113	CbGeAlD
Doxorubicin—ABCC2—lymph node—breast cancer	1.76e-05	0.00111	CbGeAlD
Doxorubicin—AURKA—Daunorubicin—Idarubicin—breast cancer	1.75e-05	0.0266	CbGdCrCtD
Doxorubicin—AURKA—Epirubicin—Idarubicin—breast cancer	1.75e-05	0.0266	CbGdCrCtD
Doxorubicin—CYP1B1—lymph node—breast cancer	1.72e-05	0.00109	CbGeAlD
Doxorubicin—CYP2B6—endocrine gland—breast cancer	1.71e-05	0.00108	CbGeAlD
Doxorubicin—ABCC1—lymph node—breast cancer	1.55e-05	0.000979	CbGeAlD
Doxorubicin—CYP3A4—female reproductive system—breast cancer	1.53e-05	0.000965	CbGeAlD
Doxorubicin—CBR3—Daunorubicin—Epirubicin—breast cancer	1.52e-05	0.0232	CbGdCrCtD
Doxorubicin—CBR3—Idarubicin—Epirubicin—breast cancer	1.52e-05	0.0232	CbGdCrCtD
Doxorubicin—CYP2D6—female reproductive system—breast cancer	1.5e-05	0.000949	CbGeAlD
Doxorubicin—ABCB1—epithelium—breast cancer	1.46e-05	0.000919	CbGeAlD
Doxorubicin—Daunorubicin—CYP3A4—breast cancer	1.4e-05	0.0152	CrCbGaD
Doxorubicin—CYP2D6—female gonad—breast cancer	1.37e-05	0.000864	CbGeAlD
Doxorubicin—ABCB1—endometrium—breast cancer	1.31e-05	0.000824	CbGeAlD
Doxorubicin—TOP2A—Topotecan—Irinotecan—breast cancer	1.3e-05	0.0199	CbGdCrCtD
Doxorubicin—CYP3A4—endocrine gland—breast cancer	1.29e-05	0.000816	CbGeAlD
Doxorubicin—ABCG2—lymph node—breast cancer	1.28e-05	0.00081	CbGeAlD
Doxorubicin—CYP2D6—endocrine gland—breast cancer	1.27e-05	0.000803	CbGeAlD
Doxorubicin—ABCB1—uterus—breast cancer	1.2e-05	0.00076	CbGeAlD
Doxorubicin—ABCB1—pituitary gland—breast cancer	1.18e-05	0.000746	CbGeAlD
Doxorubicin—ABCB1—adipose tissue—breast cancer	1.18e-05	0.000743	CbGeAlD
Doxorubicin—CBR3—Azacitidine—Gemcitabine—breast cancer	1.18e-05	0.0179	CbGdCrCtD
Doxorubicin—Daunorubicin—ABCB1—breast cancer	1.17e-05	0.0127	CrCbGaD
Doxorubicin—TOP2A—Vindesine—Vinorelbine—breast cancer	1.16e-05	0.0178	CbGdCrCtD
Doxorubicin—ABCB1—female reproductive system—breast cancer	1.08e-05	0.000683	CbGeAlD
Doxorubicin—ABCB1—adrenal gland—breast cancer	1.06e-05	0.000666	CbGeAlD
Doxorubicin—ABCB1—bone marrow—breast cancer	1.02e-05	0.000645	CbGeAlD
Doxorubicin—ABCB1—female gonad—breast cancer	9.84e-06	0.000621	CbGeAlD
Doxorubicin—CBR3—Betamethasone—Fluoxymesterone—breast cancer	9.71e-06	0.0148	CbGdCrCtD
Doxorubicin—CBR3—Dexamethasone—Fluoxymesterone—breast cancer	9.71e-06	0.0148	CbGdCrCtD
Doxorubicin—TOP2A—Vindesine—Vinblastine—breast cancer	9.31e-06	0.0142	CbGdCrCtD
Doxorubicin—ABCB1—endocrine gland—breast cancer	9.15e-06	0.000578	CbGeAlD
Doxorubicin—TOP2A—Paclitaxel—Docetaxel—breast cancer	9.14e-06	0.014	CbGdCrCtD
Doxorubicin—CBR1—Azacitidine—Gemcitabine—breast cancer	8.71e-06	0.0133	CbGdCrCtD
Doxorubicin—AURKA—Cytarabine—Gemcitabine—breast cancer	8.64e-06	0.0132	CbGdCrCtD
Doxorubicin—AURKA—Daunorubicin—Epirubicin—breast cancer	8.02e-06	0.0122	CbGdCrCtD
Doxorubicin—AURKA—Idarubicin—Epirubicin—breast cancer	8.02e-06	0.0122	CbGdCrCtD
Doxorubicin—TOP2A—Daunorubicin—Idarubicin—breast cancer	6.67e-06	0.0102	CbGdCrCtD
Doxorubicin—TOP2A—Epirubicin—Idarubicin—breast cancer	6.67e-06	0.0102	CbGdCrCtD
Doxorubicin—ABCB1—lymph node—breast cancer	6.32e-06	0.000399	CbGeAlD
Doxorubicin—TOP2A—Vincristine—Vinorelbine—breast cancer	6.28e-06	0.00959	CbGdCrCtD
Doxorubicin—TOP2A—Vinorelbine—Vinblastine—breast cancer	5.88e-06	0.00897	CbGdCrCtD
Doxorubicin—TOP2A—Vinblastine—Vinorelbine—breast cancer	5.05e-06	0.00771	CbGdCrCtD
Doxorubicin—TOP2A—Vincristine—Vinblastine—breast cancer	5.02e-06	0.00767	CbGdCrCtD
Doxorubicin—TOP2A—Methyltestosterone—Fluoxymesterone—breast cancer	4.23e-06	0.00646	CbGdCrCtD
Doxorubicin—TOP2A—Cytarabine—Gemcitabine—breast cancer	3.3e-06	0.00504	CbGdCrCtD
Doxorubicin—TOP2A—Daunorubicin—Epirubicin—breast cancer	3.06e-06	0.00467	CbGdCrCtD
Doxorubicin—TOP2A—Idarubicin—Epirubicin—breast cancer	3.06e-06	0.00467	CbGdCrCtD
Doxorubicin—TOP2A—Norethindrone—Fluoxymesterone—breast cancer	2.76e-06	0.00421	CbGdCrCtD
Doxorubicin—TOP2A—Azacitidine—Gemcitabine—breast cancer	2.37e-06	0.00361	CbGdCrCtD
Doxorubicin—Bradycardia—Epirubicin—breast cancer	2.2e-06	5.34e-05	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Paclitaxel—breast cancer	2.19e-06	5.33e-05	CcSEcCtD
Doxorubicin—Diarrhoea—Gemcitabine—breast cancer	2.19e-06	5.33e-05	CcSEcCtD
Doxorubicin—Infection—Capecitabine—breast cancer	2.19e-06	5.31e-05	CcSEcCtD
Doxorubicin—Erythema multiforme—Methotrexate—breast cancer	2.18e-06	5.3e-05	CcSEcCtD
Doxorubicin—Dizziness—Irinotecan—breast cancer	2.18e-06	5.28e-05	CcSEcCtD
Doxorubicin—Haemoglobin—Epirubicin—breast cancer	2.17e-06	5.27e-05	CcSEcCtD
Doxorubicin—Anorexia—Docetaxel—breast cancer	2.17e-06	5.27e-05	CcSEcCtD
Doxorubicin—Shock—Capecitabine—breast cancer	2.17e-06	5.26e-05	CcSEcCtD
Doxorubicin—Rhinitis—Epirubicin—breast cancer	2.16e-06	5.26e-05	CcSEcCtD
Doxorubicin—Nervous system disorder—Capecitabine—breast cancer	2.16e-06	5.25e-05	CcSEcCtD
Doxorubicin—Haemorrhage—Epirubicin—breast cancer	2.16e-06	5.24e-05	CcSEcCtD
Doxorubicin—Hepatitis—Epirubicin—breast cancer	2.16e-06	5.24e-05	CcSEcCtD
Doxorubicin—Eye disorder—Methotrexate—breast cancer	2.16e-06	5.24e-05	CcSEcCtD
Doxorubicin—Diarrhoea—Fluorouracil—breast cancer	2.16e-06	5.24e-05	CcSEcCtD
Doxorubicin—Thrombocytopenia—Capecitabine—breast cancer	2.16e-06	5.24e-05	CcSEcCtD
Doxorubicin—Tinnitus—Methotrexate—breast cancer	2.15e-06	5.23e-05	CcSEcCtD
Doxorubicin—Tachycardia—Capecitabine—breast cancer	2.15e-06	5.22e-05	CcSEcCtD
Doxorubicin—Hypoaesthesia—Epirubicin—breast cancer	2.15e-06	5.22e-05	CcSEcCtD
Doxorubicin—Pharyngitis—Epirubicin—breast cancer	2.14e-06	5.21e-05	CcSEcCtD
Doxorubicin—Cardiac disorder—Methotrexate—breast cancer	2.14e-06	5.2e-05	CcSEcCtD
Doxorubicin—Skin disorder—Capecitabine—breast cancer	2.14e-06	5.2e-05	CcSEcCtD
Doxorubicin—Urinary tract disorder—Epirubicin—breast cancer	2.13e-06	5.18e-05	CcSEcCtD
Doxorubicin—Urticaria—Paclitaxel—breast cancer	2.13e-06	5.18e-05	CcSEcCtD
Doxorubicin—Hyperhidrosis—Capecitabine—breast cancer	2.13e-06	5.17e-05	CcSEcCtD
Doxorubicin—Oedema peripheral—Epirubicin—breast cancer	2.13e-06	5.17e-05	CcSEcCtD
Doxorubicin—Hypotension—Docetaxel—breast cancer	2.12e-06	5.16e-05	CcSEcCtD
Doxorubicin—Connective tissue disorder—Epirubicin—breast cancer	2.12e-06	5.15e-05	CcSEcCtD
Doxorubicin—Body temperature increased—Paclitaxel—breast cancer	2.12e-06	5.15e-05	CcSEcCtD
Doxorubicin—Abdominal pain—Paclitaxel—breast cancer	2.12e-06	5.15e-05	CcSEcCtD
Doxorubicin—Urethral disorder—Epirubicin—breast cancer	2.12e-06	5.14e-05	CcSEcCtD
Doxorubicin—Anorexia—Capecitabine—breast cancer	2.1e-06	5.1e-05	CcSEcCtD
Doxorubicin—Angiopathy—Methotrexate—breast cancer	2.09e-06	5.08e-05	CcSEcCtD
Doxorubicin—Vomiting—Mitoxantrone—breast cancer	2.09e-06	5.08e-05	CcSEcCtD
Doxorubicin—Vomiting—Irinotecan—breast cancer	2.09e-06	5.08e-05	CcSEcCtD
Doxorubicin—Immune system disorder—Methotrexate—breast cancer	2.08e-06	5.06e-05	CcSEcCtD
Doxorubicin—Dizziness—Fluorouracil—breast cancer	2.08e-06	5.06e-05	CcSEcCtD
Doxorubicin—Visual impairment—Epirubicin—breast cancer	2.08e-06	5.05e-05	CcSEcCtD
Doxorubicin—Mediastinal disorder—Methotrexate—breast cancer	2.08e-06	5.05e-05	CcSEcCtD
Doxorubicin—Rash—Irinotecan—breast cancer	2.07e-06	5.04e-05	CcSEcCtD
Doxorubicin—Rash—Mitoxantrone—breast cancer	2.07e-06	5.04e-05	CcSEcCtD
Doxorubicin—Dermatitis—Irinotecan—breast cancer	2.07e-06	5.03e-05	CcSEcCtD
Doxorubicin—Dermatitis—Mitoxantrone—breast cancer	2.07e-06	5.03e-05	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Docetaxel—breast cancer	2.07e-06	5.03e-05	CcSEcCtD
Doxorubicin—Chills—Methotrexate—breast cancer	2.07e-06	5.03e-05	CcSEcCtD
Doxorubicin—Headache—Mitoxantrone—breast cancer	2.06e-06	5.01e-05	CcSEcCtD
Doxorubicin—Headache—Irinotecan—breast cancer	2.06e-06	5.01e-05	CcSEcCtD
Doxorubicin—Hypotension—Capecitabine—breast cancer	2.06e-06	5e-05	CcSEcCtD
Doxorubicin—Insomnia—Docetaxel—breast cancer	2.06e-06	5e-05	CcSEcCtD
Doxorubicin—Paraesthesia—Docetaxel—breast cancer	2.04e-06	4.96e-05	CcSEcCtD
Doxorubicin—Erythema multiforme—Epirubicin—breast cancer	2.04e-06	4.96e-05	CcSEcCtD
Doxorubicin—Alopecia—Methotrexate—breast cancer	2.04e-06	4.95e-05	CcSEcCtD
Doxorubicin—Vomiting—Gemcitabine—breast cancer	2.04e-06	4.95e-05	CcSEcCtD
Doxorubicin—Dyspnoea—Docetaxel—breast cancer	2.03e-06	4.92e-05	CcSEcCtD
Doxorubicin—Somnolence—Docetaxel—breast cancer	2.02e-06	4.91e-05	CcSEcCtD
Doxorubicin—Mental disorder—Methotrexate—breast cancer	2.02e-06	4.91e-05	CcSEcCtD
Doxorubicin—Rash—Gemcitabine—breast cancer	2.02e-06	4.91e-05	CcSEcCtD
Doxorubicin—Dermatitis—Gemcitabine—breast cancer	2.02e-06	4.9e-05	CcSEcCtD
Doxorubicin—Eye disorder—Epirubicin—breast cancer	2.02e-06	4.9e-05	CcSEcCtD
Doxorubicin—Tinnitus—Epirubicin—breast cancer	2.01e-06	4.89e-05	CcSEcCtD
Doxorubicin—Malnutrition—Methotrexate—breast cancer	2.01e-06	4.88e-05	CcSEcCtD
Doxorubicin—Erythema—Methotrexate—breast cancer	2.01e-06	4.88e-05	CcSEcCtD
Doxorubicin—Headache—Gemcitabine—breast cancer	2.01e-06	4.88e-05	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Capecitabine—breast cancer	2.01e-06	4.87e-05	CcSEcCtD
Doxorubicin—Cardiac disorder—Epirubicin—breast cancer	2e-06	4.87e-05	CcSEcCtD
Doxorubicin—Flushing—Epirubicin—breast cancer	2e-06	4.87e-05	CcSEcCtD
Doxorubicin—Vomiting—Fluorouracil—breast cancer	2e-06	4.87e-05	CcSEcCtD
Doxorubicin—Dyspepsia—Docetaxel—breast cancer	2e-06	4.86e-05	CcSEcCtD
Doxorubicin—Insomnia—Capecitabine—breast cancer	1.99e-06	4.84e-05	CcSEcCtD
Doxorubicin—Rash—Fluorouracil—breast cancer	1.99e-06	4.83e-05	CcSEcCtD
Doxorubicin—Dermatitis—Fluorouracil—breast cancer	1.98e-06	4.82e-05	CcSEcCtD
Doxorubicin—Paraesthesia—Capecitabine—breast cancer	1.98e-06	4.8e-05	CcSEcCtD
Doxorubicin—Decreased appetite—Docetaxel—breast cancer	1.98e-06	4.8e-05	CcSEcCtD
Doxorubicin—Hypersensitivity—Paclitaxel—breast cancer	1.98e-06	4.8e-05	CcSEcCtD
Doxorubicin—Headache—Fluorouracil—breast cancer	1.97e-06	4.79e-05	CcSEcCtD
Doxorubicin—Dysgeusia—Methotrexate—breast cancer	1.97e-06	4.78e-05	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Docetaxel—breast cancer	1.96e-06	4.77e-05	CcSEcCtD
Doxorubicin—Dyspnoea—Capecitabine—breast cancer	1.96e-06	4.77e-05	CcSEcCtD
Doxorubicin—Fatigue—Docetaxel—breast cancer	1.96e-06	4.76e-05	CcSEcCtD
Doxorubicin—Angiopathy—Epirubicin—breast cancer	1.96e-06	4.76e-05	CcSEcCtD
Doxorubicin—Nausea—Irinotecan—breast cancer	1.95e-06	4.75e-05	CcSEcCtD
Doxorubicin—Nausea—Mitoxantrone—breast cancer	1.95e-06	4.75e-05	CcSEcCtD
Doxorubicin—Immune system disorder—Epirubicin—breast cancer	1.95e-06	4.74e-05	CcSEcCtD
Doxorubicin—Mediastinal disorder—Epirubicin—breast cancer	1.95e-06	4.73e-05	CcSEcCtD
Doxorubicin—Constipation—Docetaxel—breast cancer	1.94e-06	4.72e-05	CcSEcCtD
Doxorubicin—Pain—Docetaxel—breast cancer	1.94e-06	4.72e-05	CcSEcCtD
Doxorubicin—Back pain—Methotrexate—breast cancer	1.94e-06	4.72e-05	CcSEcCtD
Doxorubicin—Dyspepsia—Capecitabine—breast cancer	1.94e-06	4.71e-05	CcSEcCtD
Doxorubicin—Chills—Epirubicin—breast cancer	1.94e-06	4.71e-05	CcSEcCtD
Doxorubicin—Arrhythmia—Epirubicin—breast cancer	1.93e-06	4.69e-05	CcSEcCtD
Doxorubicin—Asthenia—Paclitaxel—breast cancer	1.92e-06	4.68e-05	CcSEcCtD
Doxorubicin—Decreased appetite—Capecitabine—breast cancer	1.91e-06	4.65e-05	CcSEcCtD
Doxorubicin—Alopecia—Epirubicin—breast cancer	1.91e-06	4.63e-05	CcSEcCtD
Doxorubicin—Nausea—Gemcitabine—breast cancer	1.9e-06	4.62e-05	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Capecitabine—breast cancer	1.9e-06	4.62e-05	CcSEcCtD
Doxorubicin—Fatigue—Capecitabine—breast cancer	1.9e-06	4.61e-05	CcSEcCtD
Doxorubicin—Pruritus—Paclitaxel—breast cancer	1.9e-06	4.61e-05	CcSEcCtD
Doxorubicin—Vision blurred—Methotrexate—breast cancer	1.89e-06	4.6e-05	CcSEcCtD
Doxorubicin—Mental disorder—Epirubicin—breast cancer	1.89e-06	4.59e-05	CcSEcCtD
Doxorubicin—Pain—Capecitabine—breast cancer	1.88e-06	4.57e-05	CcSEcCtD
Doxorubicin—Constipation—Capecitabine—breast cancer	1.88e-06	4.57e-05	CcSEcCtD
Doxorubicin—Erythema—Epirubicin—breast cancer	1.88e-06	4.57e-05	CcSEcCtD
Doxorubicin—Malnutrition—Epirubicin—breast cancer	1.88e-06	4.57e-05	CcSEcCtD
Doxorubicin—Feeling abnormal—Docetaxel—breast cancer	1.87e-06	4.55e-05	CcSEcCtD
Doxorubicin—Nausea—Fluorouracil—breast cancer	1.87e-06	4.55e-05	CcSEcCtD
Doxorubicin—Ill-defined disorder—Methotrexate—breast cancer	1.86e-06	4.53e-05	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Docetaxel—breast cancer	1.86e-06	4.52e-05	CcSEcCtD
Doxorubicin—Anaemia—Methotrexate—breast cancer	1.86e-06	4.51e-05	CcSEcCtD
Doxorubicin—Flatulence—Epirubicin—breast cancer	1.85e-06	4.5e-05	CcSEcCtD
Doxorubicin—Tension—Epirubicin—breast cancer	1.84e-06	4.48e-05	CcSEcCtD
Doxorubicin—Dysgeusia—Epirubicin—breast cancer	1.84e-06	4.47e-05	CcSEcCtD
Doxorubicin—Diarrhoea—Paclitaxel—breast cancer	1.84e-06	4.46e-05	CcSEcCtD
Doxorubicin—Nervousness—Epirubicin—breast cancer	1.83e-06	4.43e-05	CcSEcCtD
Doxorubicin—Back pain—Epirubicin—breast cancer	1.82e-06	4.42e-05	CcSEcCtD
Doxorubicin—Feeling abnormal—Capecitabine—breast cancer	1.81e-06	4.41e-05	CcSEcCtD
Doxorubicin—Malaise—Methotrexate—breast cancer	1.81e-06	4.4e-05	CcSEcCtD
Doxorubicin—Muscle spasms—Epirubicin—breast cancer	1.81e-06	4.39e-05	CcSEcCtD
Doxorubicin—Vertigo—Methotrexate—breast cancer	1.8e-06	4.38e-05	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Capecitabine—breast cancer	1.8e-06	4.37e-05	CcSEcCtD
Doxorubicin—Abdominal pain—Docetaxel—breast cancer	1.8e-06	4.37e-05	CcSEcCtD
Doxorubicin—Body temperature increased—Docetaxel—breast cancer	1.8e-06	4.37e-05	CcSEcCtD
Doxorubicin—Leukopenia—Methotrexate—breast cancer	1.8e-06	4.37e-05	CcSEcCtD
Doxorubicin—Dizziness—Paclitaxel—breast cancer	1.77e-06	4.31e-05	CcSEcCtD
Doxorubicin—Vision blurred—Epirubicin—breast cancer	1.77e-06	4.3e-05	CcSEcCtD
Doxorubicin—Cough—Methotrexate—breast cancer	1.75e-06	4.26e-05	CcSEcCtD
Doxorubicin—Urticaria—Capecitabine—breast cancer	1.75e-06	4.25e-05	CcSEcCtD
Doxorubicin—Ill-defined disorder—Epirubicin—breast cancer	1.74e-06	4.24e-05	CcSEcCtD
Doxorubicin—Body temperature increased—Capecitabine—breast cancer	1.74e-06	4.23e-05	CcSEcCtD
Doxorubicin—Abdominal pain—Capecitabine—breast cancer	1.74e-06	4.23e-05	CcSEcCtD
Doxorubicin—Convulsion—Methotrexate—breast cancer	1.74e-06	4.23e-05	CcSEcCtD
Doxorubicin—Anaemia—Epirubicin—breast cancer	1.74e-06	4.22e-05	CcSEcCtD
Doxorubicin—Agitation—Epirubicin—breast cancer	1.73e-06	4.2e-05	CcSEcCtD
Doxorubicin—Myalgia—Methotrexate—breast cancer	1.71e-06	4.15e-05	CcSEcCtD
Doxorubicin—Chest pain—Methotrexate—breast cancer	1.71e-06	4.15e-05	CcSEcCtD
Doxorubicin—Arthralgia—Methotrexate—breast cancer	1.71e-06	4.15e-05	CcSEcCtD
Doxorubicin—Vomiting—Paclitaxel—breast cancer	1.71e-06	4.14e-05	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	1.7e-06	4.12e-05	CcSEcCtD
Doxorubicin—Malaise—Epirubicin—breast cancer	1.69e-06	4.12e-05	CcSEcCtD
Doxorubicin—Rash—Paclitaxel—breast cancer	1.69e-06	4.11e-05	CcSEcCtD
Doxorubicin—Dermatitis—Paclitaxel—breast cancer	1.69e-06	4.11e-05	CcSEcCtD
Doxorubicin—Discomfort—Methotrexate—breast cancer	1.69e-06	4.1e-05	CcSEcCtD
Doxorubicin—Vertigo—Epirubicin—breast cancer	1.69e-06	4.1e-05	CcSEcCtD
Doxorubicin—Syncope—Epirubicin—breast cancer	1.69e-06	4.09e-05	CcSEcCtD
Doxorubicin—Leukopenia—Epirubicin—breast cancer	1.68e-06	4.09e-05	CcSEcCtD
Doxorubicin—Headache—Paclitaxel—breast cancer	1.68e-06	4.08e-05	CcSEcCtD
Doxorubicin—Hypersensitivity—Docetaxel—breast cancer	1.68e-06	4.07e-05	CcSEcCtD
Doxorubicin—Palpitations—Epirubicin—breast cancer	1.66e-06	4.03e-05	CcSEcCtD
Doxorubicin—Confusional state—Methotrexate—breast cancer	1.65e-06	4.01e-05	CcSEcCtD
Doxorubicin—Loss of consciousness—Epirubicin—breast cancer	1.65e-06	4.01e-05	CcSEcCtD
Doxorubicin—Cough—Epirubicin—breast cancer	1.64e-06	3.98e-05	CcSEcCtD
Doxorubicin—Anaphylactic shock—Methotrexate—breast cancer	1.64e-06	3.98e-05	CcSEcCtD
Doxorubicin—Asthenia—Docetaxel—breast cancer	1.63e-06	3.96e-05	CcSEcCtD
Doxorubicin—Convulsion—Epirubicin—breast cancer	1.63e-06	3.96e-05	CcSEcCtD
Doxorubicin—Infection—Methotrexate—breast cancer	1.63e-06	3.96e-05	CcSEcCtD
Doxorubicin—Hypertension—Epirubicin—breast cancer	1.62e-06	3.94e-05	CcSEcCtD
Doxorubicin—Hypersensitivity—Capecitabine—breast cancer	1.62e-06	3.94e-05	CcSEcCtD
Doxorubicin—Pruritus—Docetaxel—breast cancer	1.61e-06	3.91e-05	CcSEcCtD
Doxorubicin—Nervous system disorder—Methotrexate—breast cancer	1.61e-06	3.9e-05	CcSEcCtD
Doxorubicin—Thrombocytopenia—Methotrexate—breast cancer	1.6e-06	3.9e-05	CcSEcCtD
Doxorubicin—Myalgia—Epirubicin—breast cancer	1.6e-06	3.89e-05	CcSEcCtD
Doxorubicin—Chest pain—Epirubicin—breast cancer	1.6e-06	3.89e-05	CcSEcCtD
Doxorubicin—Arthralgia—Epirubicin—breast cancer	1.6e-06	3.89e-05	CcSEcCtD
Doxorubicin—Anxiety—Epirubicin—breast cancer	1.59e-06	3.87e-05	CcSEcCtD
Doxorubicin—Nausea—Paclitaxel—breast cancer	1.59e-06	3.87e-05	CcSEcCtD
Doxorubicin—Skin disorder—Methotrexate—breast cancer	1.59e-06	3.87e-05	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	1.59e-06	3.86e-05	CcSEcCtD
Doxorubicin—Hyperhidrosis—Methotrexate—breast cancer	1.58e-06	3.85e-05	CcSEcCtD
Doxorubicin—Discomfort—Epirubicin—breast cancer	1.58e-06	3.84e-05	CcSEcCtD
Doxorubicin—Asthenia—Capecitabine—breast cancer	1.58e-06	3.84e-05	CcSEcCtD
Doxorubicin—Dry mouth—Epirubicin—breast cancer	1.56e-06	3.8e-05	CcSEcCtD
Doxorubicin—Anorexia—Methotrexate—breast cancer	1.56e-06	3.8e-05	CcSEcCtD
Doxorubicin—Pruritus—Capecitabine—breast cancer	1.56e-06	3.78e-05	CcSEcCtD
Doxorubicin—Diarrhoea—Docetaxel—breast cancer	1.56e-06	3.78e-05	CcSEcCtD
Doxorubicin—Confusional state—Epirubicin—breast cancer	1.55e-06	3.76e-05	CcSEcCtD
Doxorubicin—Anaphylactic shock—Epirubicin—breast cancer	1.53e-06	3.73e-05	CcSEcCtD
Doxorubicin—Oedema—Epirubicin—breast cancer	1.53e-06	3.73e-05	CcSEcCtD
Doxorubicin—Hypotension—Methotrexate—breast cancer	1.53e-06	3.72e-05	CcSEcCtD
Doxorubicin—Infection—Epirubicin—breast cancer	1.52e-06	3.7e-05	CcSEcCtD
Doxorubicin—Shock—Epirubicin—breast cancer	1.51e-06	3.67e-05	CcSEcCtD
Doxorubicin—Diarrhoea—Capecitabine—breast cancer	1.51e-06	3.66e-05	CcSEcCtD
Doxorubicin—Nervous system disorder—Epirubicin—breast cancer	1.5e-06	3.65e-05	CcSEcCtD
Doxorubicin—Dizziness—Docetaxel—breast cancer	1.5e-06	3.65e-05	CcSEcCtD
Doxorubicin—Thrombocytopenia—Epirubicin—breast cancer	1.5e-06	3.65e-05	CcSEcCtD
Doxorubicin—Tachycardia—Epirubicin—breast cancer	1.5e-06	3.64e-05	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Methotrexate—breast cancer	1.49e-06	3.63e-05	CcSEcCtD
Doxorubicin—Skin disorder—Epirubicin—breast cancer	1.49e-06	3.62e-05	CcSEcCtD
Doxorubicin—Hyperhidrosis—Epirubicin—breast cancer	1.48e-06	3.6e-05	CcSEcCtD
Doxorubicin—Insomnia—Methotrexate—breast cancer	1.48e-06	3.6e-05	CcSEcCtD
Doxorubicin—Paraesthesia—Methotrexate—breast cancer	1.47e-06	3.58e-05	CcSEcCtD
Doxorubicin—Anorexia—Epirubicin—breast cancer	1.46e-06	3.55e-05	CcSEcCtD
Doxorubicin—Dyspnoea—Methotrexate—breast cancer	1.46e-06	3.55e-05	CcSEcCtD
Doxorubicin—Somnolence—Methotrexate—breast cancer	1.46e-06	3.54e-05	CcSEcCtD
Doxorubicin—Dizziness—Capecitabine—breast cancer	1.46e-06	3.54e-05	CcSEcCtD
Doxorubicin—Vomiting—Docetaxel—breast cancer	1.45e-06	3.51e-05	CcSEcCtD
Doxorubicin—Dyspepsia—Methotrexate—breast cancer	1.44e-06	3.5e-05	CcSEcCtD
Doxorubicin—Rash—Docetaxel—breast cancer	1.43e-06	3.48e-05	CcSEcCtD
Doxorubicin—Hypotension—Epirubicin—breast cancer	1.43e-06	3.48e-05	CcSEcCtD
Doxorubicin—Dermatitis—Docetaxel—breast cancer	1.43e-06	3.48e-05	CcSEcCtD
Doxorubicin—Decreased appetite—Methotrexate—breast cancer	1.42e-06	3.46e-05	CcSEcCtD
Doxorubicin—Headache—Docetaxel—breast cancer	1.42e-06	3.46e-05	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Methotrexate—breast cancer	1.41e-06	3.44e-05	CcSEcCtD
Doxorubicin—Fatigue—Methotrexate—breast cancer	1.41e-06	3.43e-05	CcSEcCtD
Doxorubicin—Pain—Methotrexate—breast cancer	1.4e-06	3.4e-05	CcSEcCtD
Doxorubicin—Vomiting—Capecitabine—breast cancer	1.4e-06	3.4e-05	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Epirubicin—breast cancer	1.4e-06	3.39e-05	CcSEcCtD
Doxorubicin—Rash—Capecitabine—breast cancer	1.39e-06	3.37e-05	CcSEcCtD
Doxorubicin—Insomnia—Epirubicin—breast cancer	1.39e-06	3.37e-05	CcSEcCtD
Doxorubicin—Dermatitis—Capecitabine—breast cancer	1.39e-06	3.37e-05	CcSEcCtD
Doxorubicin—Headache—Capecitabine—breast cancer	1.38e-06	3.35e-05	CcSEcCtD
Doxorubicin—Paraesthesia—Epirubicin—breast cancer	1.38e-06	3.35e-05	CcSEcCtD
Doxorubicin—Dyspnoea—Epirubicin—breast cancer	1.37e-06	3.32e-05	CcSEcCtD
Doxorubicin—Somnolence—Epirubicin—breast cancer	1.36e-06	3.31e-05	CcSEcCtD
Doxorubicin—Nausea—Docetaxel—breast cancer	1.35e-06	3.28e-05	CcSEcCtD
Doxorubicin—Feeling abnormal—Methotrexate—breast cancer	1.35e-06	3.28e-05	CcSEcCtD
Doxorubicin—Dyspepsia—Epirubicin—breast cancer	1.35e-06	3.28e-05	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Methotrexate—breast cancer	1.34e-06	3.26e-05	CcSEcCtD
Doxorubicin—Decreased appetite—Epirubicin—breast cancer	1.33e-06	3.24e-05	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Epirubicin—breast cancer	1.32e-06	3.22e-05	CcSEcCtD
Doxorubicin—Fatigue—Epirubicin—breast cancer	1.32e-06	3.21e-05	CcSEcCtD
Doxorubicin—Pain—Epirubicin—breast cancer	1.31e-06	3.19e-05	CcSEcCtD
Doxorubicin—Constipation—Epirubicin—breast cancer	1.31e-06	3.19e-05	CcSEcCtD
Doxorubicin—Nausea—Capecitabine—breast cancer	1.31e-06	3.18e-05	CcSEcCtD
Doxorubicin—Urticaria—Methotrexate—breast cancer	1.3e-06	3.16e-05	CcSEcCtD
Doxorubicin—Abdominal pain—Methotrexate—breast cancer	1.3e-06	3.15e-05	CcSEcCtD
Doxorubicin—Body temperature increased—Methotrexate—breast cancer	1.3e-06	3.15e-05	CcSEcCtD
Doxorubicin—Feeling abnormal—Epirubicin—breast cancer	1.26e-06	3.07e-05	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Epirubicin—breast cancer	1.25e-06	3.05e-05	CcSEcCtD
Doxorubicin—Urticaria—Epirubicin—breast cancer	1.22e-06	2.96e-05	CcSEcCtD
Doxorubicin—Abdominal pain—Epirubicin—breast cancer	1.21e-06	2.95e-05	CcSEcCtD
Doxorubicin—Body temperature increased—Epirubicin—breast cancer	1.21e-06	2.95e-05	CcSEcCtD
Doxorubicin—Hypersensitivity—Methotrexate—breast cancer	1.21e-06	2.93e-05	CcSEcCtD
Doxorubicin—Asthenia—Methotrexate—breast cancer	1.18e-06	2.86e-05	CcSEcCtD
Doxorubicin—Pruritus—Methotrexate—breast cancer	1.16e-06	2.82e-05	CcSEcCtD
Doxorubicin—Hypersensitivity—Epirubicin—breast cancer	1.13e-06	2.75e-05	CcSEcCtD
Doxorubicin—Diarrhoea—Methotrexate—breast cancer	1.12e-06	2.72e-05	CcSEcCtD
Doxorubicin—Asthenia—Epirubicin—breast cancer	1.1e-06	2.67e-05	CcSEcCtD
Doxorubicin—Pruritus—Epirubicin—breast cancer	1.09e-06	2.64e-05	CcSEcCtD
Doxorubicin—Dizziness—Methotrexate—breast cancer	1.08e-06	2.63e-05	CcSEcCtD
Doxorubicin—Diarrhoea—Epirubicin—breast cancer	1.05e-06	2.55e-05	CcSEcCtD
Doxorubicin—Vomiting—Methotrexate—breast cancer	1.04e-06	2.53e-05	CcSEcCtD
Doxorubicin—Rash—Methotrexate—breast cancer	1.03e-06	2.51e-05	CcSEcCtD
Doxorubicin—Dermatitis—Methotrexate—breast cancer	1.03e-06	2.51e-05	CcSEcCtD
Doxorubicin—Headache—Methotrexate—breast cancer	1.03e-06	2.49e-05	CcSEcCtD
Doxorubicin—Dizziness—Epirubicin—breast cancer	1.01e-06	2.46e-05	CcSEcCtD
Doxorubicin—Vomiting—Epirubicin—breast cancer	9.75e-07	2.37e-05	CcSEcCtD
Doxorubicin—Nausea—Methotrexate—breast cancer	9.74e-07	2.36e-05	CcSEcCtD
Doxorubicin—Rash—Epirubicin—breast cancer	9.67e-07	2.35e-05	CcSEcCtD
Doxorubicin—Dermatitis—Epirubicin—breast cancer	9.66e-07	2.35e-05	CcSEcCtD
Doxorubicin—Headache—Epirubicin—breast cancer	9.61e-07	2.33e-05	CcSEcCtD
Doxorubicin—Nausea—Epirubicin—breast cancer	9.11e-07	2.21e-05	CcSEcCtD
Doxorubicin—CYP3A4—Metabolism—ABCC1—breast cancer	2.09e-07	7.55e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—JUN—breast cancer	2.09e-07	7.54e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—RAF1—breast cancer	2.09e-07	7.53e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—HMOX1—breast cancer	2.07e-07	7.49e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CTNNB1—breast cancer	2.07e-07	7.49e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ITPR1—breast cancer	2.07e-07	7.47e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—ERBB2—breast cancer	2.06e-07	7.45e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CYP2D6—breast cancer	2.06e-07	7.42e-06	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MAPK3—breast cancer	2.04e-07	7.38e-06	CbGpPWpGaD
Doxorubicin—NOS3—Disease—PIK3CA—breast cancer	2.04e-07	7.35e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PIK3CB—breast cancer	2.04e-07	7.35e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MTOR—breast cancer	2.04e-07	7.35e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MMP9—breast cancer	2.03e-07	7.34e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CD4—breast cancer	2.03e-07	7.33e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CDKN1A—breast cancer	2.03e-07	7.31e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PPARGC1B—breast cancer	2.03e-07	7.31e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PTEN—breast cancer	2.02e-07	7.3e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—NCOA2—breast cancer	2.02e-07	7.29e-06	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—PIK3CA—breast cancer	2.02e-07	7.29e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PTGS2—breast cancer	2.02e-07	7.28e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CYP17A1—breast cancer	2e-07	7.21e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ABCB1—breast cancer	1.99e-07	7.19e-06	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MYC—breast cancer	1.99e-07	7.18e-06	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TGFB1—breast cancer	1.98e-07	7.16e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MAPK8—breast cancer	1.98e-07	7.14e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ENO1—breast cancer	1.98e-07	7.13e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PTGS1—breast cancer	1.98e-07	7.13e-06	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—AKT1—breast cancer	1.97e-07	7.11e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	1.96e-07	7.08e-06	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PTEN—breast cancer	1.96e-07	7.08e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—FASN—breast cancer	1.96e-07	7.07e-06	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PIK3CG—breast cancer	1.96e-07	7.07e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PIK3CD—breast cancer	1.96e-07	7.06e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—TYMS—breast cancer	1.96e-07	7.06e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—BCHE—breast cancer	1.95e-07	7.04e-06	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—EGFR—breast cancer	1.94e-07	7.02e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PLA2G4A—breast cancer	1.93e-07	6.98e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—NCOR1—breast cancer	1.93e-07	6.98e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GSTM1—breast cancer	1.93e-07	6.98e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—ALB—breast cancer	1.93e-07	6.97e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—SLC5A5—breast cancer	1.93e-07	6.95e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CA9—breast cancer	1.91e-07	6.9e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GSTA4—breast cancer	1.91e-07	6.9e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CDKN1B—breast cancer	1.91e-07	6.9e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—NCOA2—breast cancer	1.9e-07	6.87e-06	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PIK3CD—breast cancer	1.89e-07	6.83e-06	CbGpPWpGaD
Doxorubicin—NOS3—Disease—HRAS—breast cancer	1.88e-07	6.8e-06	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PTEN—breast cancer	1.88e-07	6.79e-06	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—PIK3CA—breast cancer	1.88e-07	6.77e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—SRC—breast cancer	1.87e-07	6.77e-06	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—ALB—breast cancer	1.87e-07	6.74e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GPX2—breast cancer	1.86e-07	6.73e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GSTA2—breast cancer	1.86e-07	6.73e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—SLC2A1—breast cancer	1.86e-07	6.71e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—NQO1—breast cancer	1.86e-07	6.71e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GPX1—breast cancer	1.85e-07	6.68e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—NOS3—breast cancer	1.85e-07	6.67e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—FASN—breast cancer	1.84e-07	6.66e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GPX4—breast cancer	1.84e-07	6.65e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SULT1A1—breast cancer	1.84e-07	6.65e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—BCHE—breast cancer	1.84e-07	6.63e-06	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—KRAS—breast cancer	1.84e-07	6.63e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CYP1A1—breast cancer	1.83e-07	6.61e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—VEGFA—breast cancer	1.83e-07	6.59e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ERCC2—breast cancer	1.82e-07	6.56e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—SLC5A5—breast cancer	1.81e-07	6.55e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CYP3A4—breast cancer	1.81e-07	6.55e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—STAT3—breast cancer	1.81e-07	6.53e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CTNNB1—breast cancer	1.8e-07	6.52e-06	CbGpPWpGaD
Doxorubicin—NOS3—Disease—IL6—breast cancer	1.8e-07	6.51e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—IDH1—breast cancer	1.8e-07	6.49e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GSTA1—breast cancer	1.8e-07	6.49e-06	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—NOS3—breast cancer	1.79e-07	6.45e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CYP1B1—breast cancer	1.78e-07	6.44e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—NAT2—breast cancer	1.78e-07	6.42e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	1.77e-07	6.4e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CDKN1A—breast cancer	1.76e-07	6.36e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PTEN—breast cancer	1.76e-07	6.35e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—NQO1—breast cancer	1.75e-07	6.33e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—SLC2A1—breast cancer	1.75e-07	6.33e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—HSP90AA1—breast cancer	1.75e-07	6.31e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MAPK3—breast cancer	1.73e-07	6.24e-06	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PIK3CD—breast cancer	1.72e-07	6.21e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CYP3A4—breast cancer	1.71e-07	6.17e-06	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—AKT1—breast cancer	1.71e-07	6.17e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—MTHFR—breast cancer	1.71e-07	6.17e-06	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—PIK3CA—breast cancer	1.71e-07	6.16e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PIK3CB—breast cancer	1.7e-07	6.15e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—NCOA1—breast cancer	1.7e-07	6.14e-06	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ALB—breast cancer	1.7e-07	6.13e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PTGS2—breast cancer	1.69e-07	6.1e-06	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—PIK3CA—breast cancer	1.69e-07	6.09e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CYP1B1—breast cancer	1.68e-07	6.07e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MYC—breast cancer	1.68e-07	6.06e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CYP19A1—breast cancer	1.68e-07	6.05e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—STK11—breast cancer	1.68e-07	6.05e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TGFB1—breast cancer	1.68e-07	6.05e-06	CbGpPWpGaD
Doxorubicin—NOS3—Disease—AKT1—breast cancer	1.66e-07	6.01e-06	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—AKT1—breast cancer	1.65e-07	5.95e-06	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PIK3CB—breast cancer	1.65e-07	5.95e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—HSP90AA1—breast cancer	1.65e-07	5.95e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—EGFR—breast cancer	1.64e-07	5.93e-06	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PTGS2—breast cancer	1.63e-07	5.9e-06	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TP53—breast cancer	1.63e-07	5.89e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—SRC—breast cancer	1.63e-07	5.89e-06	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—NOS3—breast cancer	1.63e-07	5.87e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—NCOA1—breast cancer	1.6e-07	5.79e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—STK11—breast cancer	1.58e-07	5.7e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CYP19A1—breast cancer	1.58e-07	5.7e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CAV1—breast cancer	1.58e-07	5.69e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—STAT3—breast cancer	1.57e-07	5.68e-06	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—HRAS—breast cancer	1.56e-07	5.64e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—DPYD—breast cancer	1.56e-07	5.63e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—MED12—breast cancer	1.56e-07	5.63e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—COMT—breast cancer	1.56e-07	5.63e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—KRAS—breast cancer	1.55e-07	5.6e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GSTP1—breast cancer	1.55e-07	5.6e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ALDOA—breast cancer	1.53e-07	5.54e-06	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—AKT1—breast cancer	1.53e-07	5.53e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—HMOX1—breast cancer	1.53e-07	5.52e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ITPR1—breast cancer	1.53e-07	5.51e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MAPK3—breast cancer	1.5e-07	5.43e-06	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PIK3CB—breast cancer	1.5e-07	5.42e-06	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IL6—breast cancer	1.49e-07	5.4e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—NCOA3—breast cancer	1.49e-07	5.38e-06	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PTGS2—breast cancer	1.49e-07	5.37e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SLC2A2—breast cancer	1.48e-07	5.34e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PTEN—breast cancer	1.47e-07	5.32e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—COMT—breast cancer	1.47e-07	5.3e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MYC—breast cancer	1.46e-07	5.28e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GSTP1—breast cancer	1.46e-07	5.28e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—TGFB1—breast cancer	1.46e-07	5.26e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CPT1A—breast cancer	1.45e-07	5.23e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ABCG2—breast cancer	1.45e-07	5.23e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—MTR—breast cancer	1.45e-07	5.23e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—TYMS—breast cancer	1.44e-07	5.21e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—HMOX1—breast cancer	1.44e-07	5.2e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ITPR1—breast cancer	1.44e-07	5.19e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PIK3CG—breast cancer	1.44e-07	5.18e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—EGFR—breast cancer	1.43e-07	5.16e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PIK3CA—breast cancer	1.43e-07	5.15e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—NCOR1—breast cancer	1.43e-07	5.15e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GSTM1—breast cancer	1.43e-07	5.15e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PLA2G4A—breast cancer	1.43e-07	5.15e-06	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PTEN—breast cancer	1.42e-07	5.14e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—HPGDS—breast cancer	1.42e-07	5.13e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—HBA1—breast cancer	1.41e-07	5.1e-06	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—AKT1—breast cancer	1.39e-07	5.03e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ABCB1—breast cancer	1.38e-07	5e-06	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PIK3CA—breast cancer	1.38e-07	4.99e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TP53—breast cancer	1.38e-07	4.98e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GSTT1—breast cancer	1.38e-07	4.98e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ACHE—breast cancer	1.38e-07	4.98e-06	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—AKT1—breast cancer	1.38e-07	4.98e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GPX1—breast cancer	1.37e-07	4.93e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—TYMS—breast cancer	1.36e-07	4.91e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CYP1A1—breast cancer	1.35e-07	4.88e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—KRAS—breast cancer	1.35e-07	4.88e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PLA2G4A—breast cancer	1.34e-07	4.85e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GSTM1—breast cancer	1.34e-07	4.85e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—NCOR1—breast cancer	1.34e-07	4.85e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ERCC2—breast cancer	1.34e-07	4.84e-06	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PIK3CA—breast cancer	1.33e-07	4.79e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—HRAS—breast cancer	1.32e-07	4.76e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CYP17A1—breast cancer	1.31e-07	4.71e-06	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PTEN—breast cancer	1.3e-07	4.68e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ENO1—breast cancer	1.29e-07	4.66e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PTGS1—breast cancer	1.29e-07	4.66e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GPX1—breast cancer	1.29e-07	4.64e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CYP1A1—breast cancer	1.27e-07	4.6e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CYP2D6—breast cancer	1.27e-07	4.57e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ERCC2—breast cancer	1.26e-07	4.56e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IL6—breast cancer	1.26e-07	4.56e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PIK3CD—breast cancer	1.26e-07	4.55e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—MTHFR—breast cancer	1.26e-07	4.55e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ALB—breast cancer	1.25e-07	4.5e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—NCOA2—breast cancer	1.24e-07	4.49e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PIK3CA—breast cancer	1.24e-07	4.48e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—FASN—breast cancer	1.21e-07	4.35e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—BCHE—breast cancer	1.2e-07	4.34e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—NOS3—breast cancer	1.19e-07	4.3e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—MTHFR—breast cancer	1.19e-07	4.29e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SLC5A5—breast cancer	1.19e-07	4.28e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—AKT1—breast cancer	1.17e-07	4.21e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CAV1—breast cancer	1.16e-07	4.19e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—HRAS—breast cancer	1.15e-07	4.14e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—NQO1—breast cancer	1.15e-07	4.14e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SLC2A1—breast cancer	1.15e-07	4.14e-06	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—AKT1—breast cancer	1.13e-07	4.08e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PIK3CB—breast cancer	1.1e-07	3.97e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—IL6—breast cancer	1.1e-07	3.97e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CYP1B1—breast cancer	1.1e-07	3.97e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CAV1—breast cancer	1.1e-07	3.95e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PTGS2—breast cancer	1.09e-07	3.93e-06	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—AKT1—breast cancer	1.08e-07	3.91e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.08e-07	3.89e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PIK3CG—breast cancer	1.06e-07	3.82e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—NCOA1—breast cancer	1.05e-07	3.78e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PIK3CA—breast cancer	1.04e-07	3.75e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CYP19A1—breast cancer	1.03e-07	3.73e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—STK11—breast cancer	1.03e-07	3.73e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—AKT1—breast cancer	1.01e-07	3.66e-06	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PIK3CA—breast cancer	1.01e-07	3.63e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PIK3CG—breast cancer	9.97e-08	3.6e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—COMT—breast cancer	9.6e-08	3.47e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GSTP1—breast cancer	9.56e-08	3.45e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PTEN—breast cancer	9.5e-08	3.43e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—HMOX1—breast cancer	9.43e-08	3.4e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ITPR1—breast cancer	9.4e-08	3.39e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PIK3CD—breast cancer	9.31e-08	3.36e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ALB—breast cancer	9.19e-08	3.32e-06	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PIK3CA—breast cancer	9.14e-08	3.3e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ABCB1—breast cancer	9.05e-08	3.27e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—TYMS—breast cancer	8.88e-08	3.21e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—NOS3—breast cancer	8.79e-08	3.17e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GSTM1—breast cancer	8.78e-08	3.17e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—NCOR1—breast cancer	8.78e-08	3.17e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PLA2G4A—breast cancer	8.78e-08	3.17e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PIK3CD—breast cancer	8.77e-08	3.17e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ALB—breast cancer	8.66e-08	3.12e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—AKT1—breast cancer	8.49e-08	3.06e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GPX1—breast cancer	8.41e-08	3.04e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CYP1A1—breast cancer	8.33e-08	3.01e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—NOS3—breast cancer	8.28e-08	2.99e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ERCC2—breast cancer	8.26e-08	2.98e-06	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—AKT1—breast cancer	8.21e-08	2.96e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PIK3CB—breast cancer	8.11e-08	2.93e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PTGS2—breast cancer	8.04e-08	2.9e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—MTHFR—breast cancer	7.76e-08	2.8e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PIK3CB—breast cancer	7.64e-08	2.76e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PTGS2—breast cancer	7.57e-08	2.73e-06	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—AKT1—breast cancer	7.47e-08	2.7e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CAV1—breast cancer	7.16e-08	2.58e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PTEN—breast cancer	7.01e-08	2.53e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PIK3CA—breast cancer	6.7e-08	2.42e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PTEN—breast cancer	6.6e-08	2.38e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PIK3CG—breast cancer	6.52e-08	2.35e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PIK3CD—breast cancer	5.73e-08	2.07e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ALB—breast cancer	5.66e-08	2.04e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—AKT1—breast cancer	5.48e-08	1.98e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—NOS3—breast cancer	5.41e-08	1.95e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PIK3CB—breast cancer	5e-08	1.8e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PTGS2—breast cancer	4.95e-08	1.79e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PIK3CA—breast cancer	4.94e-08	1.78e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PIK3CA—breast cancer	4.66e-08	1.68e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PTEN—breast cancer	4.32e-08	1.56e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—AKT1—breast cancer	4.04e-08	1.46e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—AKT1—breast cancer	3.81e-08	1.37e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PIK3CA—breast cancer	3.05e-08	1.1e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—AKT1—breast cancer	2.49e-08	8.98e-07	CbGpPWpGaD
